Page 1 | Search Results | Blood | American Society of Hematology

1-9 of 9

Sort by

Sort Order Select

Journal Articles

Transplant Outcomes in High-Risk (Class 3) Patients with Thalassemia Treated with a Modified Protocol Are Equivalent to Low/Intermediate-Risk (Class 1/Class 2) Patients

Javid Gaziev, MD, Gioia De Angelis, MD, Antonella Isgro, MD, Pietro Sodani, MD, Marco Marziali, MD, Katia Paciaroni, MD, Marco Andreani, PhD, Manuela Testi, PhD, Cristiano Gallucci, MD, Cecilia Alfieri, MD, Michela Ribersani, MD, Maria Troiano, PhD, Aldo Morrone, MD, Guido Lucarelli, MD

Blood (2015) 126 (23): 620.

https://doi.org/10.1182/blood.V126.23.620.620

Published: 2015

Journal Articles

Hematopoietic Stem Cell Transplantation in Nigerian Children with Sickle Cell Anemia

Antonella Isgro, MD, Javid Gaziev, Pietro Sodani, MD, Marco Andreani, PhD, Manuela Testi, PhD, Katia Paciaroni, MD, Cristiano Gallucci, MD, Gioia De Angelis, MD, Marco Marziali, MD, Cecilia Alfieri, MD, Michela Ribersani, MD, Olufemi O Akinyanju, T. Thompson Wakama, Festus Olusola Olowoselu, Guido Lucarelli, MD

Blood (2015) 126 (23): 4598.

https://doi.org/10.1182/blood.V126.23.4598.4598

Published: 2015

Journal Articles

Type of Relapse in 91 Newly Diagnosed MM Patients Treated with High Dose Chemotherapy Followed by Autologous Stem Cell Transplantation.

Maria Teresa Petrucci, MD, Giuseppe Avvisati, MD, PhD, Ombretta Annibali, MD, Saveria Capria, MD, Maria S. De Propris, PhD, Patrizia Del Bianco, PhD, Vincenzo Federico, Cristiano Gallucci, MD, Maria Gozzer, MD, Chiara Gregorj, PhD, Annalisa Natale, MD, Azzurra Romeo, MD, Giovanna Meloni, MD, Robert Foa, MD

Blood (2006) 108 (11): 5451.

https://doi.org/10.1182/blood.V108.11.5451.5451

Published: 2006

Journal Articles

Velcade as Retreatment of Multiple Myeloma Patients Previously Responsive to Velcade.

Maria Teresa Petrucci, MD, Cristiano Gallucci, MD, Vincenzo Federico, Patrizia Del Bianco, PhD, Robert Foa, MD

Blood (2006) 108 (11): 5088.

https://doi.org/10.1182/blood.V108.11.5088.5088

Published: 2006

Journal Articles

Possible Role of Ozone Therapy in the Treatment of Osteonecrosis of the Jaws in Multiple Myeloma Patients.

Cristiano Gallucci, MD, Alessandro Agrillo, MD, Giorgio Iannetti, MD, Robert Foà, MD, Maria Teresa Petrucci, MD

Blood (2005) 106 (11): 3460.

https://doi.org/10.1182/blood.V106.11.3460.3460

Published: 2005

Journal Articles

Velcade an Active Agent for Multiple Myeloma Patients. Experience of a Single Center.

Maria Teresa Petrucci, MD, Vincenza Martini, MD, Cristiano Gallucci, MD, Erica Finolezzi, MD, Anna Levi, MD, Patrizia Del Bianco, PhD, Franco Mandelli, MD, Robert Foà, MD

Blood (2005) 106 (11): 5151.

https://doi.org/10.1182/blood.V106.11.5151.5151

Published: 2005

Journal Articles

Long Term Follow-Up of 198 IgM Monoclonal Gammopathy of Undetermined Significance (MGUS).

Ombretta Annibali, MD, Maria T. Petrucci, MD, Francesco Bartolozzi, MD, Anna Levi, MD, Patrizia Del Bianco, BSc, Cristiano Gallucci, MD, Robin Foa, MD, Franco Mandelli, MD, Giuseppe Avvisati, MD.PhD

Blood (2004) 104 (11): 4859.

https://doi.org/10.1182/blood.V104.11.4859.4859

Published: 2004

Journal Articles

Natural History of 656 Patients with Non IgM MGUS.

Carolina Nobile, MD, Maria T. Petrucci, MD, Francesco Bartolozzi, MD, Anna Levi, MD, Marianna De Muro, MD, Maria C. Tirindelli, MD, Patrizia Del Bianco, BSc, Cristiano Gallucci, MD, Franco Mandelli, MD, Giuseppe Avvisati, MD

Blood (2004) 104 (11): 4860.

https://doi.org/10.1182/blood.V104.11.4860.4860

Published: 2004

Journal Articles

Oral Melphalan, Cyclophosfamide and Prednisone (MCP) in 72 Newly Diagnosed Waldenström’s Macroglobulinemia Patients: Results and Costs Analysis.

Maria Teresa Petrucci, MD, Ombretta Annibali, MD, Anna Levi, MD, Maria C. Tirindelli, MD, Carolina Fossati, MD, Cristiano Gallucci, MD, Patrizia Del Bianco, BSc, Franco Mandelli, MD, Giuseppe Avvisati, MD, PhD

Blood (2004) 104 (11): 3298.

https://doi.org/10.1182/blood.V104.11.3298.3298

Published: 2004

NARROW

Transplant Outcomes in High-Risk (Class 3) Patients with Thalassemia Treated with a Modified Protocol Are Equivalent to Low/Intermediate-Risk (Class 1/Class 2) Patients

Hematopoietic Stem Cell Transplantation in Nigerian Children with Sickle Cell Anemia

Type of Relapse in 91 Newly Diagnosed MM Patients Treated with High Dose Chemotherapy Followed by Autologous Stem Cell Transplantation.

Velcade as Retreatment of Multiple Myeloma Patients Previously Responsive to Velcade.

Possible Role of Ozone Therapy in the Treatment of Osteonecrosis of the Jaws in Multiple Myeloma Patients.

Velcade an Active Agent for Multiple Myeloma Patients. Experience of a Single Center.

Long Term Follow-Up of 198 IgM Monoclonal Gammopathy of Undetermined Significance (MGUS).

Natural History of 656 Patients with Non IgM MGUS.

Oral Melphalan, Cyclophosfamide and Prednisone (MCP) in 72 Newly Diagnosed Waldenström’s Macroglobulinemia Patients: Results and Costs Analysis.

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only